Drug
UBT251 clinical trials
Also written UBT251.
- studies test it
- 12
- open now
- 12
- in phase 3
- 5
- first study started
- 2025
Keep track of what changes. Save the UBT251 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
12 studies that test it; most in 2026 (10)
| Year | Studies |
|---|---|
| 2025 | 2 |
| 2026 | 10 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 4
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
The United Bio-Technology (Hengqin) Co., Ltd. (8) · Novo Nordisk A/S (4)
Often tested with
Tested in the same studies.
Contraceptives, Oral (1) · Acetaminophen (1) · Metformin (1) · Warfarin (1) · Digoxin (1)
Studies
Open first, then newest update. How each study uses UBT251 is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 DiabetesRecruitingPhase 2Novo Nordisk A/SNCT07668388Written as UBT251
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1)RecruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07659574Written as UBT251 Injection 2.0 mg
- Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)RecruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07653477Written as UBT251 Injection 2.0 mg group
- UBT251 Injection Phase Ⅲ Study (OSA-PAP)Not yet recruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07806851Written as UBT251
- UBT251 Injection Phase Ⅲ Study (OSA-NPAP)Not yet recruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07767942Written as UBT251
- A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become PregnantRecruitingPhase 1Novo Nordisk A/SNCT07710729Written as UBT251
- Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or ObesityRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07785934Written as UBT251
- A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body WeightRecruitingPhase 1Novo Nordisk A/SNCT07710768Written as UBT251
- UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)Not yet recruitingPhase 3The United Bio-Technology (Hengqin) Co., Ltd.NCT07648225Written as UBT251 Injection 4.0 mg
- A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or ObesityRecruitingPhase 2Novo Nordisk A/SNCT07395687Written as UBT251
- UBT251 Injection Phase II Clinical Study (CKD)RecruitingPhase 2The United Bio-Technology (Hengqin) Co., Ltd.NCT07134335Written as UBT251
- A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)RecruitingPhase 2The United Bio-Technology (Hengqin) Co., Ltd.NCT07145151Written as UBT251